Evidence map›Paper›PMID 20200423›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2010

Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.

Kristi D Graves, Lari Wenzel, Marc D Schwartz, George Luta, Paul Wileyto, Steven Narod, Beth N Peshkin, Alfred Marcus, David Cella, Susan Powell Emsbo and 2 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Assessing Psychological Morbidity in Cancer-UnaffectedCurrent oncology (Toronto, Ont.) · 2023
    Pooled it
  2. Pooled it
  3. Psychosocial telephone counseling for survivors of cervical cancer: results of a randomized biobehavioral trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2015
    Trial
  4. Intervention completion rates among African Americans in a randomized effectiveness trial for diet and physical activity changes.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Trial
  5. Trial
  6. Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease.Genetics in medicine : official journal of the American College of Medical Genetics · 2012
    Trial
  7. Equity in Genomic Medicine.Annual review of genomics and human genetics · 2022
    Review
  8. Article
  9. Review
  10. Psychometric Properties of the MICRA Questionnaire in Portuguese Individuals Carrying SDHx Mutations.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Communication of genetic test results to family and health-care providers following disclosure of research results.Genetics in medicine : official journal of the American College of Medical Genetics · 2014
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Kristi D GravesDepartment of Oncology and The Fisher Centerfor Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Street, Northwest, Suite 4100, Washington, DC 20007, USA. kdg9@georgetown.edu
Lari Wenzel
Marc D Schwartz
George Luta
Paul Wileyto
Steven Narod
Beth N Peshkin
Alfred Marcus
David Cella
Susan Powell Emsbo
Denise Barnes
Chanita Hughes Halbert
Northwestern University · USCancer Research Center · USUniversity of California, Irvine · USGeorgetown University · USUniversity of Colorado Cancer Center · USUniversity of Colorado Denver · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
The Role of Behavioral Science in Personalized Genetic MedicineK07CA131172 · NCI · GEORGETOWN UNIVERSITY · PI GRAVES, KRISTI D. · 2008 to 2012
$785k
COMPARING MODELS OF COUNSELING FOR BRCA1/2 TESTINGR01HG001846 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI HUGHES-HALBERT, CHANITA A · 1998 to 2000
$535k
NCI NIH HHS K07 CA131172NCI NIH HHS K07CA131172NCI NIH HHS P30 CA062203NHGRI NIH HHS HG01846
6 · The paper itself

Abstract

backgroundResponses following BRCA1/2 genetic testing are relevant for the comprehension of risk status and may play a role in risk management decision making. The objective of this study was to evaluate a psychosocial telephone counseling (PTC) intervention delivered to BRCA1/2 mutation carriers following standard genetic counseling (SGC). We examined the effect of the intervention on distress and the concerns related to genetic testing.

methodsThis prospective randomized clinical trial included 90 BRCA1/2 mutation carriers. We measured anxiety, depression, and genetic testing distress outcomes at intervention baseline and 6 and 12 months following disclosure. We evaluated the effects of SGC versus SGC plus PTC on psychological outcomes using intention-to-treat analyses through generalized estimating equations.

resultsAt 6 months, PTC reduced depressive symptoms (Z = -2.25, P = 0.02) and genetic testing distress (Z = 2.18, P = 0.02) compared with SGC. Furthermore, women in the intervention condition reported less clinically significant anxiety at 6 months (chi(2)(1) = 4.11, P = 0.04) than women who received SGC. We found no differences in outcomes between the intervention groups at the 12-month follow-up.

conclusionsAs an adjunct to SGC, PTC delivered following disclosure of positive BRCA1/2 test results seems to offer modest short-term benefits for distress and anxiety. These results build upon a growing literature of psychosocial interventions for BRCA1/2 carriers and, given the potential impact of affect on risk management decision making, suggest that some carriers may derive benefits from adjuncts to traditional genetic counseling.

Indexed as

Genes, BRCA1Genes, BRCA2FemaleGenetic CounselingGenetic Predisposition to DiseaseHumansMutationTelephone

Identifiers

PMID20200423
PMCPMC2849295
OpenAlexW2142853150

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.